AIDS Alert Archives – December 1, 2003
December 1, 2003
View Issues
-
Multicampus outbreak of HIV in North Carolina spurs quick state action
An HIV RNA screening program in North Carolina has uncovered the beginning of an outbreak of HIV infection among college students and has led state health officials to speculate that the outbreak could have an impact on youth across the Southeast. -
State works with colleges on testing and prevention
North Carolinas recent discovery of an HIV outbreak among college students across a wide network of universities has made the public health challenge clear: Either make effective prevention, testing, and counseling services available to at-risk youths, or expect in a few years to add more young people to the states waiting list for HIV medications. -
How a Nashville church became prevention leader
The Metropolitan Interdenominational Church of Nashville, TN, was about 3 years old in 1984 when the congregation learned that one of the founding members had died of a little-known disease called AIDS. -
Church becomes leader in mobilizing others
When a Nashville, TN, church spreads the word about HIV/AIDS education, the repercussions can be felt hundreds of miles away. -
Study: Syphilitic hepatitis connected to liver disease
Investigators in Washington, DC, have discovered cases of HIV patients who have significant liver dysfunction that is caused by secondary syphilis instead of the usual suspects of hepatitis C, medication side effects, and substance abuse. -
Primary care doctors fail to offer tests, survey says
A new survey shows that most primary care practitioners often fail to offer HIV testing to their sexually active patients, and many even neglect to offer the test to pregnant patients. -
AIDSinfo starts new Live Help web service
AIDSinfo recently began a new service on its web site called Live Help. AIDSinfo is a web site sponsored by agencies within the Department of Health and Human Services. -
Gilead issues letter about virologic failure
Gilead Sciences Inc. in Forest City, CA, has issued a Dear Health Care Professional letter describing high rates of virologic failure in patients treated with a once-daily triple NRTI regimen containing Didanosine (ddI, Videx EC), Lamivudine (3TC, Epivir), and Tenofovir (Viread).